Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
Translational and Integrative Medicine Research Fund at Memorial Sloan Kettering Cancer Center
Received: 26 October 2020
Accepted: 24 December 2020
First Online: 28 January 2021
Compliance with ethical standards
: Dr. Mao reports grants from Tibet Cheezheng Tibetan Medicine Co., Ltd. and from Zhongke Health International, LLC outside the submitted work. Dr. Harte reports grants and personal fees from Aptinyx, and grants and other from Arbor Medical Innovations, outside the submitted work. In addition, Dr. Harte has a patent US9307906 licensed. Dr. Panageas reports other from Johnson and Johnson, Pfizer, Viking Therapeutics, and Catalyst Biotech, outside the submitted work. All other authors report no potential conflicts of interest.